The use of selexipag, a prostacyclin receptor analog, for treatment of severe pulmonary artery hypertension during pregnancy, a case report

Pregnancy in patients with pulmonary artery hypertension (PAH) is associated with high mortality and morbidity. Despite the risks, more patients with PAH are becoming pregnant. Case reports and case series have described the use of IV epoprostenol in these patients with some success. However, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Akram, Hubel, Kinsley, Brookfield, Kathleen, Pak, Jonathan, Allada, Gopal, Gause, Sherie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374956/
https://www.ncbi.nlm.nih.gov/pubmed/37521130
http://dx.doi.org/10.1016/j.rmcr.2023.101895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374956/
https://www.ncbi.nlm.nih.gov/pubmed/37521130
http://dx.doi.org/10.1016/j.rmcr.2023.101895

Ejemplares similares